首页 >
法规速递
-
Document: Medicinal products for human use: monthly figures - January 2025-2025/2/25
2025-02-27查看详情 > -
Page: Tolvaptan product-specific bioequivalence guidance-2025/4/2
2025-04-03查看详情 > -
Document: Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026-2025/5/13
2025-05-14查看详情 > -
Document: Concept paper for the development of a guideline on the methodology of environmental risk assessment for ectoparasiticidal VMPs for cats and dogs-2025/6/20
2025-06-23查看详情 > -
Document: Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders-2025/7/25
2025-07-27查看详情 > -
Development of Non-Opioid Analgesics for Chronic Pain-2025/9/10
2025-09-11查看详情 > -
Document: Pool of healthcare professional experts: list for 2024-2029-2025/10/14
2025-10-15查看详情 > -
图解海报 | 《医疗器械生产质量管理规范》系列解读(十)-2025/11/19
2025-11-20查看详情 > -
关于公开征求《ICH M13A低风险制剂清单》(第一批)意见的通知-2025/12/15
2025-12-15查看详情 > -
国家药监局药审中心关于发布《化学药品创新药晶型研究技术指导原则(试行)》的通告(2026年第10号)-2026/1/28
2026-01-28查看详情 >